Affordable Access

Management of unfavorable locoregional prostate carcinoma with radiation and androgen ablation.

Authors
Type
Published Article
Journal
Cancer
Publication Date
Volume
80
Issue
4
Pages
764–775
Identifiers
PMID: 9264361
Source
Medline
License
Unknown

Abstract

Unfavorable locoregional prostate carcinoma can be recognized on the basis of pretreatment PSA level, T category, and Gleason's grade without specific evaluation of pelvic lymph node status. Combined local radiation and androgen ablation for patients with unfavorable disease results in a substantial improvement in disease control compared with that achieved by either modality alone. The authors found no improvement in survival because all groups of men had a normal life expectancy to at least 5 years.

Statistics

Seen <100 times